3FEI | Transcription | date | Nov 30, 2008 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Design And Biological Evaluation Of Novel, Balanced Dual Ppa Agonists | ||||||||||||||
authors | J.Benz, U.Grether, B.Gsell, A.Binggeli, H.Hilpert, H.P.Maerki, P.M A.Ruf, M.Stihle, D.Schlatter | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Peroxisome Proliferator-Activated Receptor Alpha Chain: A Fragment: Pparalpha Ligand Binding Domain Synonym: Ppar-Alpha, Nuclear Receptor Subfamily 1 Group C M Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Ppara, Nr1c1, Ppar Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_vector_type: Plasmid Expression_system_plasmid: Pet15b | ||||||||||||||
Molecule: Peptide Motif 5 Of Nuclear Receptor Coactivator 1 Chain: Z Synonym: Src-1 Coactivator Protein Motif 5 Engineered: Yes |
Synthetic: Yes Other_details: Chemically Synthesis | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.40 Å | ||||||||||||
ligand | CTM | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists., Grether U, Benardeau A, Benz J, Binggeli A, Blum D, Hilpert H, Kuhn B, Marki HP, Meyer M, Mohr P, Puntener K, Raab S, Ruf A, Schlatter D, ChemMedChem. 2009 Jun;4(6):951-6. PMID:19326383 |
Data retrieval |
View 3FEI in 3D |
Visual 3D analysis of 3FEI |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3FEI |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |